eMedicine Specialties > Emergency Medicine > Infectious Diseases

Coccidioidomycosis: Follow-up

Author: James de la Torre, MD, Staff Physician, Resident Emergency Medicine, Department of Emergency Medicine, University of Southern California/Los Angeles County Medical Center
Coauthor(s): Allison J Richard, MD, Instructor of Clinical Emergency Medicine, Keck School of Medicine, University of Southern California; Consulting Staff, Department of Emergency Medicine, LAC-USC Medical Center; Joseph Kim, MD, Chairman, Department of Emergency Medicine, Western Medical Center; Clinical Instructor, University of California at Irvine
Contributor Information and Disclosures

Updated: May 27, 2008

Follow-up

Further Inpatient Care

Indications for admission include the following:

  • Immunocompromised conditions
  • Dissemination
  • Any need for symptomatic support or intravenous therapy

Complications

  • Severe cases are fatal, particularly if associated with meningitis.
  • Obstruction of pulmonary tissue due to scarring or cavities may occur.

Prognosis

  • Most cases are self-limited and resolve within a few months.
  • Prognosis is poor if the patient has a weak cell-mediated immunity or high IgG.
  • Relapse of extrapulmonary or disseminated disease is common.

Patient Education

  • Educate populations at high risk (eg, immunocompromised, pregnant women, African Americans, Filipinos, those with diabetes) on avoidance of high-risk activities (eg, construction, archeological digs).

Miscellaneous

Medicolegal Pitfalls

  • Failure to consider this or other fungal infections in patients in whom other therapies have failed and in those who appear to have a chronic illness or are resident of (or traveler to) endemic regions is a pitfall.
  • Recently, coccidioidomycosis has regained interest due to its potential as a bioterrorism weapon.11 C immitis is listed in some texts as a potential agent for biological warfare. Although the exact outcome of an attack is unknown, C immitis possesses some properties that could make it attractive as a weapon. In particular, spores can be disseminated and aerosolized rather easily. However, the infectivity in this capacity is unknown and effects are probably limited.
 


More on Coccidioidomycosis

Overview: Coccidioidomycosis
Differential Diagnoses & Workup: Coccidioidomycosis
Treatment & Medication: Coccidioidomycosis
Follow-up: Coccidioidomycosis
References
[ CLOSE WINDOW ]

References

  1. Ampel NM. Combating opportunistic infections: coccidioidomycosis. Expert Opin Pharmacother. Feb 2004;5(2):255-61. [Medline].

  2. CDC. Coccidioidomycosis following the Northridge earthquake--California, 1994. JAMA. Jun 8 1994;271(22):1735. [Medline].

  3. Schneider E, Hajjeh RA, Spiegel RA, et al. A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA. Mar 19 1997;277(11):904-8. [Medline].

  4. Bergstrom L, Yocum DE, Ampel NM. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists. Arthritis Rheum. Jun 2004;50(6):1959-66. [Medline].

  5. CDC. Increase in coccidioidomycosis--Arizona, 1998-2001. MMWR Morb Mortal Wkly Rep. Feb 14 2003;52(6):109-12. [Medline].

  6. Louie L, Ng S, Hajjeh R, et al. Influence of host genetics on the severity of coccidioidomycosis. Emerg Infect Dis. Sep-Oct 1999;5(5):672-80. [Medline].

  7. Galgiani JN, Catanzaro A, Cloud GA. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. Ann Intern Med. Nov 7 2000;133(9):676-86. [Medline].

  8. Prabhu RM, Bonnell M, Currier BL. Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole. Clin Infect Dis. Oct 1 2004;39(7):e74-7. [Medline].

  9. Anstead GM, Corcoran G, Lewis J. Refractory coccidioidomycosis treated with posaconazole. Clin Infect Dis. Jun 15 2005;40(12):1770-6. [Medline].

  10. Park DW, Sohn JW, Cheong HJ. Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole. BMC Infect Dis. 2006;6:26. [Medline].

  11. Deresinski S. Coccidioides immitis as a potential bioweapon. Semin Respir Infect. Sep 2003;18(3):216-9. [Medline].

  12. Blair JE, Smilack JD, Caples SM. Coccidioidomycosis in patients with hematologic malignancies. Arch Intern Med. Jan 10 2005;165(1):113-7. [Medline].

  13. Catanzaro A. Coccidioidomycosis. In: Manual of Clinical Problems in Pulmonary Medicine. 5th ed. Lippincott Williams & Wilkins; 2000.

  14. Comrie AC. Climate factors influencing coccidioidomycosis seasonality and outbreaks. Environ Health Perspect. Jun 2005;113(6):688-92. [Medline].

  15. Deresinski SC, Mirels LF, Kemper CA. Coccidioides immitis. In: Infectious Diseases. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:2227-46.

  16. Galgiani J. Coccidioides immitis. In: Principles and Practice of Infectious Diseases. New York, NY: Churchill Livingstone; 2000:2746-57.

  17. Jones JL, Fleming PL, Ciesielski CA, et al. Coccidioidomycosis among persons with AIDS in the United States. J Infect Dis. Apr 1995;171(4):961-6. [Medline].

  18. Rosenstein NE, Emery KW, Werner SB. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis. Mar 1 2001;32(5):708-15. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

coccidioidomycosis, desert fever, Posadas-Wernicke disease, San Joaquin fever, San Joaquin Valley Fever, cocci fungal infection, Coccidioides immitis, CI, arthroconidia, extrapulmonary coccidioidomycosis disease, human immunodeficiency virus, HIV, acquired immunodeficiency syndrome, AIDS, certain lymphomas, posttransplant states, chronic steroid dependence, severe pulmonary infection, erythema nodosum, desert rheumatism, pneumonia, hemoptysis, pneumothorax, noncommunicating hydrocephalus, increased intracranial pressure, pericardial effusion, tamponade, osteomyelitis, septic arthritis, synovitis

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

James de la Torre, MD, Staff Physician, Resident Emergency Medicine, Department of Emergency Medicine, University of Southern California/Los Angeles County Medical Center
Disclosure: Nothing to disclose.

Coauthor(s)

Allison J Richard, MD, Instructor of Clinical Emergency Medicine, Keck School of Medicine, University of Southern California; Consulting Staff, Department of Emergency Medicine, LAC-USC Medical Center
Allison J Richard, MD is a member of the following medical societies: International Society of Travel Medicine
Disclosure: Nothing to disclose.

Joseph Kim, MD, Chairman, Department of Emergency Medicine, Western Medical Center; Clinical Instructor, University of California at Irvine
Disclosure: Nothing to disclose.

Medical Editor

David FM Brown, MD, Assistant Professor, Department of Medicine, Division of Emergency Medicine, Harvard Medical School; Associate-Chief, Attending Physician, Department of Emergency Medicine, Massachusetts General Hospital
David FM Brown, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Barry J Sheridan, DO, Chief, Department of Emergency Medical Services, Brooke Army Medical Center
Barry J Sheridan, DO is a member of the following medical societies: American Academy of Emergency Medicine
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Barry E Brenner, MD, PhD, FACEP, Program Director, Department of Emergency Medicine, University Hospitals, Case Medical Center
Barry E Brenner, MD, PhD, FACEP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Chest Physicians, American College of Emergency Physicians, American College of Physicians, American Heart Association, American Thoracic Society, Arkansas Medical Society, New York Academy of Medicine, New York Academy of Sciences, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.